Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Gemiwel
Gemiwel 1000 mg is an intravenous chemotherapy injection containing Gemcitabine, a powerful anti-cancer agent used to treat various malignancies such as lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer. It works by inhibiting DNA synthesis in cancer cells, leading to tumor regression.
Uses of Gemiwel
Treatment of non-small cell lung cancer (NSCLC).
Effective in pancreatic, breast, bladder, and ovarian cancer.
Used alone or in combination with other chemotherapy drugs.
Helps improve survival rates and reduce tumor burden.
Benefits of Gemiwel
Targets rapidly dividing cancer cells, slowing tumor progression.
Can be used as first-line or second-line chemotherapy.
Combination therapy potential for enhanced effectiveness.
Well-established safety and efficacy profile.
Mechanism of Action of Gemiwel
Acts as a nucleoside analog, disrupting DNA replication.
Prevents cancer cell division and induces apoptosis (programmed cell death).
Interferes with tumor growth and reduces metastasis risk.